JP2008535800A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535800A5
JP2008535800A5 JP2008501331A JP2008501331A JP2008535800A5 JP 2008535800 A5 JP2008535800 A5 JP 2008535800A5 JP 2008501331 A JP2008501331 A JP 2008501331A JP 2008501331 A JP2008501331 A JP 2008501331A JP 2008535800 A5 JP2008535800 A5 JP 2008535800A5
Authority
JP
Japan
Prior art keywords
fel
seq
chain
composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008501331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008535800A (ja
JP5302671B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/060845 external-priority patent/WO2006097530A2/en
Publication of JP2008535800A publication Critical patent/JP2008535800A/ja
Publication of JP2008535800A5 publication Critical patent/JP2008535800A5/ja
Application granted granted Critical
Publication of JP5302671B2 publication Critical patent/JP5302671B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008501331A 2005-03-18 2006-03-17 ネコアレルゲンコンジュゲートとその使用 Expired - Fee Related JP5302671B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66291805P 2005-03-18 2005-03-18
US60/662,918 2005-03-18
PCT/EP2006/060845 WO2006097530A2 (en) 2005-03-18 2006-03-17 Cat allergen fusion proteins and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013048847A Division JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Publications (3)

Publication Number Publication Date
JP2008535800A JP2008535800A (ja) 2008-09-04
JP2008535800A5 true JP2008535800A5 (https=) 2009-05-07
JP5302671B2 JP5302671B2 (ja) 2013-10-02

Family

ID=36843236

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008501331A Expired - Fee Related JP5302671B2 (ja) 2005-03-18 2006-03-17 ネコアレルゲンコンジュゲートとその使用
JP2013048847A Pending JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013048847A Pending JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Country Status (19)

Country Link
US (3) US7767212B2 (https=)
EP (1) EP1868642B1 (https=)
JP (2) JP5302671B2 (https=)
KR (1) KR20070112225A (https=)
CN (2) CN103203016A (https=)
AU (1) AU2006224529B2 (https=)
BR (1) BRPI0608455A2 (https=)
CA (1) CA2599218C (https=)
CY (1) CY1114171T1 (https=)
DK (1) DK1868642T3 (https=)
ES (1) ES2424229T3 (https=)
IL (1) IL185103A0 (https=)
MX (1) MX2007011160A (https=)
NZ (1) NZ561040A (https=)
PL (1) PL1868642T3 (https=)
PT (1) PT1868642E (https=)
RU (1) RU2414239C2 (https=)
WO (1) WO2006097530A2 (https=)
ZA (1) ZA200707413B (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
DE60234375D1 (de) 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
US7138252B2 (en) * 2002-07-17 2006-11-21 Cytos Biotechnology Ag Molecular antigen arrays
EP2338510A1 (en) * 2002-07-19 2011-06-29 Novartis Pharma AG Vaccine compositions containing amyloid beta1-6 antigen arrays
ZA200707413B (en) * 2005-03-18 2009-01-28 Cytos Biotechnology Ag Cat allergen fusion proteins and uses thereof
CA2636139A1 (en) * 2005-12-14 2007-06-21 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007113633A2 (en) * 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
US8541559B2 (en) 2006-06-12 2013-09-24 Cytos Biotechnology Ag Process for producing aggregated oligonucleotides
EP2066354B1 (en) 2006-09-29 2013-04-17 Ligocyte Pharmaceuticals, Inc. Norovirus vaccine formulations
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
ES2599639T3 (es) * 2007-07-09 2017-02-02 Nestec S.A. Procedimientos para reducir las alergias causadas por alérgenos ambientales
CN104740624B (zh) 2007-09-18 2018-04-24 武田疫苗股份有限公司 赋予针对诺如病毒的保护性免疫应答的疫苗
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
EP2042193A1 (en) * 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
NO2324113T3 (https=) 2008-08-08 2018-07-28
BR112013011069A2 (pt) * 2009-11-05 2017-03-28 Padgett Hal geração de partículas antigênicas semelhantes a virus através de ligações de proteína-proteína
US8321012B2 (en) 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
EP4112074A1 (en) 2011-07-11 2023-01-04 Takeda Vaccines, Inc. Parenteral norovirus vaccine formulations
CN104011080B (zh) 2011-12-22 2017-10-20 弗·哈夫曼-拉罗切有限公司 用于真核细胞的全长抗体展示系统及其用途
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
EP3587455A1 (en) * 2012-10-23 2020-01-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
US10935554B2 (en) 2013-08-23 2021-03-02 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT)
JP2017512213A (ja) * 2013-12-19 2017-05-18 ネステク ソシエテ アノニム 環境中のネコアレルゲンを減少するための組成物及び方法
MA40824A (fr) * 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
WO2016112921A1 (en) 2015-01-15 2016-07-21 University Of Copenhagen Virus-like particle with efficient epitope display
WO2016192788A1 (en) * 2015-06-03 2016-12-08 Universität Zürich Prorektorat Mnw Methods and compositions for preventing and treating cat or dog dander allergy
HK1255206A1 (zh) * 2015-09-08 2019-08-09 苏黎世大学 抗猫过敏的组合物
EP3368068B1 (en) 2015-10-30 2020-11-18 University of Copenhagen Virus like particle with efficient epitope display
CN105219742A (zh) * 2015-11-10 2016-01-06 海南大学 一种展示重组猫致敏原rFel d 1蛋白的免疫增强型病毒样颗粒、其表达载体及其制备与应用
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
FR3054547B1 (fr) * 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations
RS67826B1 (sr) 2016-12-22 2026-03-31 Regeneron Pharma Postupak za lečenje alergije sa monoklonskim antitelima specifičnim za alergen
JP7623282B2 (ja) 2018-12-20 2025-01-28 サイバ アクチェンゲゼルシャフト 融合によって修飾されたｃｍｖのウイルス様粒子
WO2023176206A1 (ja) * 2022-03-18 2023-09-21 デンカ株式会社 リンカーにより連結されたカプシドタンパク質を含むウイルス様粒子
CN114933639B (zh) * 2022-05-05 2023-12-29 中国农业科学院兰州兽医研究所 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途
CN117004650B (zh) * 2023-06-25 2024-05-14 山东立菲生物产业有限公司 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用
WO2025139524A1 (zh) * 2023-12-28 2025-07-03 江苏众红生物工程创药研究院有限公司 猫重组变应原及其药用组合物、制备方法和应用
WO2025194374A1 (zh) * 2024-03-20 2025-09-25 深圳赫兹生命科学技术有限公司 猫过敏原多肽片段及应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163778A (en) * 1978-05-04 1979-08-07 The Foundation for the Study of Asthma and Related Diseases Asthma immunotherapy
US5374426A (en) * 1986-09-03 1994-12-20 University Of Saskatchewan Rotavirus nucleocapsid protein VP6 in vaccine compositions
DE68924850T2 (de) * 1988-06-14 1996-10-10 Cell Med Inc Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
US6120769A (en) * 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
EP0563091A1 (en) 1990-12-20 1993-10-06 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccines based on hepatitis b surface antigen
GB9114003D0 (en) * 1991-06-28 1991-08-14 Mastico Robert A Chimaeric protein
GB9213601D0 (en) * 1992-06-26 1992-08-12 Mastico Robert A Protein based delivery system
EP0783322A1 (en) 1994-09-02 1997-07-16 Immunologic Pharmaceutical Corporation Peptide compositions capable of down regulating an antigen specific immune response
US6759234B1 (en) * 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
CN1185811A (zh) 1995-03-31 1998-06-24 H·沃尔夫 依赖于逆转录病毒样颗粒的抗原呈递系统
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
EP1037663A2 (en) * 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
AR020102A1 (es) 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
WO2000020032A1 (en) 1998-10-06 2000-04-13 Trustees Of Dartmouth College RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
DE69929232T2 (de) * 1998-10-21 2006-08-31 The United States Government As Represented By The Department Of Health And Human Services Virusähnliche partikel zur induktion von autoantikörpern
MXPA01005389A (es) * 1998-11-30 2003-03-27 Cytos Biotechnology Ag Presentacion molecular ordenada de antigenos, metodos de preparacion y uso.
NZ517929A (en) 1999-09-25 2004-02-27 Univ Iowa Res Found Immunostimulatory nucleic acids
CA2407897A1 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
ATE414773T1 (de) 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
DE60032250T2 (de) * 2000-12-28 2007-03-15 Biomay Produktions- Und Handels-Aktiengesellschaft Behandlung von Allergien
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
WO2002070665A2 (en) 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
CA2492823A1 (en) 2001-09-14 2003-03-27 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
DE60234375D1 (de) 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
AU2002363382B2 (en) * 2001-11-07 2007-07-19 Cytos Biotechnology Ag Antigen arrays presenting IL-5, IL-3 or eotaxin for treatment of allergic eosinophilic diseases
ES2316628T3 (es) * 2001-11-07 2009-04-16 Cytos Biotechnology Ag Disposicion ordenada de antigenos que comprende rankl para el tratamiento de enfermedades oseas.
US7138252B2 (en) 2002-07-17 2006-11-21 Cytos Biotechnology Ag Molecular antigen arrays
ATE441429T1 (de) 2002-07-19 2009-09-15 Cytos Biotechnology Ag Ghrelin-träger-konjugate
WO2004018506A2 (en) * 2002-08-22 2004-03-04 Cytos Biotechnology Ag Inducible alphaviral/orip based gene expression system
CA2503886A1 (en) 2002-11-01 2004-05-13 Alk-Abello A/S Recombinant protein variants
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
AU2004224761A1 (en) * 2003-03-26 2004-10-07 Cytos Biotechnology Ag HIV-peptide-carrier-conjugates
DE602004011502T2 (de) * 2003-04-24 2009-01-22 Imvision Gmbh Rekombinantes fel d 1 allergen
RU2375076C2 (ru) * 2003-07-10 2009-12-10 Цитос Биотехнологи Аг Укомплектованные вирусоподобные частицы
ZA200707413B (en) * 2005-03-18 2009-01-28 Cytos Biotechnology Ag Cat allergen fusion proteins and uses thereof

Similar Documents

Publication Publication Date Title
JP2008535800A5 (https=)
Jennings et al. The coming of age of virus-like particle vaccines.
JP5084103B2 (ja) ハプテン担体抱合体およびその用法
JP2014521684A5 (https=)
JP2004522736A5 (https=)
JP2008529558A5 (https=)
RU2007138265A (ru) Белки, слитые с кошачьим аллергеном, и их применение
JP2008517975A (ja) 胃酸分泌抑制ポリペプチド（ｇｉｐ）抗原アッセイ及びその使用
JP2009510025A5 (https=)
JP2008523132A (ja) Ｉｌ−１５抗原アレイとその使用法
ES2320638T3 (es) Disposicion ordenada de antigenos il-5, il-13 o eotasina, para el tratamiento de enfermedades alergicas con un componente eosinofilico.
MXPA04011247A (es) Conjugados portadores de grelina.
JP2006504653A5 (https=)
JP2008530245A5 (https=)
JP2006516116A5 (https=)
JP2011521662A5 (https=)
JP2016521539A (ja) マラリアワクチン
EP3049107A1 (en) Self-assembled nanoparticle vaccines
JP2015509707A5 (https=)
CN112292391A (zh) 用与细胞因子连接的ecm亲和肽治疗癌症的方法和组合物
JP2009520758A5 (https=)
JP2010508857A5 (https=)
JP2010506926A5 (https=)
JP2010538619A5 (https=)
RU2006130006A (ru) Конъюгаты грелин-носитель